In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

Coverage for these medications varies widely across plans; while many employers cover GLP-1 for diabetes treatment, fewer ...

Poor bowel preparation also led to repeat colonoscopies for 18.9% of current GLP-1RA users, compared to 11.1% of controls ...

Glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy offers significant glycemic benefits ... Wright, Abbott, Sylmar, ...

IDF creating new Type 2 diabetes guidelines with global experts, focusing on patient-centered care and global accessibility.

The warning affects all treatments containing GLP-1 receptor agonists, including semaglutide ( Ozempic, Wegovy, Rybelsus ), ...

Viking Therapeutics' weight loss drug VK2735 may challenge Novo Nordisk and Eli Lilly's dominance in the obesity drug space ...

A trial, targeted at people living with obesity from Britain to Puerto Rico, is the first head-to-head comparison of the weight-loss effects of the two blockbuster slimming jabs ...

Sodium glucose cotransporter 2 inhibitors used to treat diabetes may also reduce the risk of recurrent kidney stones and gout ...

“When we compare bariatric surgery to bariatric endoscopy ... and to discover differences between comparing the two ...

Rapid weight loss can cause a greater loss of muscle mass than losing weight slowly. The popularity of newer weight-loss ...